This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Catalyst Pharmaceuticals Inc. advanced 2.8% to $24.28 on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 0.5% to 17,461.32 and the Dow Jones Industrial Average rising 0.7% to 40,527.62.
This was the stock's sixth consecutive day of gains.
Catalyst Pharmaceuticals Inc. closed 7.2% below its 52-week high of $26.16, which the company achieved on March 24th.
The stock demonstrated a mixed performance when compared to some of its competitors, as Johnson & Johnson rose 0.4% to $155.91, Pfizer Inc. rose 3.2% to $23.79, and Abbott Laboratories rose 0.75% to $130.50.
Trading volume totaled 714,812, compared to the 50-day average of 1.3 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
April 29, 2025 16:35 ET (20:35 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。